| |MARCH 202619QUICK FACTS· Year of Establishment: 1985· Office Locations: Delhi (headquarter) and Panipat, with five manufacturing plants ­ one in Panipat (Haryana), three in Paonta Sahib (Himachal Pradesh), and another in Karnal (Haryana)· Key Product Categories: Injections, Ophthalmic Preparations, Tablets, Capsules, Dry & Liquid Syrups, Topical Preparations, Ayurveda Medicines, and Cosmeticsinitial production stage to the final packaging of the product under sterile conditions, thus minimizing the risk of any error or contamination. All the production units comprise of high capacity German & Chinese machinery that facilitates production of large quanti-ties of products while simultaneously maintaining high quality standards, Overall, Laborate's per-day production across all its facilities are 200,000 vials, 300,000 ampoules, 300,000 oph-thalmic, 200,000 tubes of topical preparations, 300,000 dry in-jections, 2 million capsules, 15 million tablets, 100,000 bottles of dry syrup, and 100,000 bottles of liquid syrups/emulsions. Additionally, the company also has a full-fledged F&D team that is engaged in the development of wide range of dosage forms such as Solid & Liquid orals, creams & ointments, oph-thalmic preparations, small volume parenteral, cosmetic for-mulations, and many more."At Laborate, we strongly believe that a product will rule the market only when it conforms to world-class standards and the quality requirement of customers ­ first time and every time. While our quality control team consists of 150+ highly qualified personnel, including PhD holders, M.Phil and post-graduates, our technical team has been one of the corner-stones of our operations and instrumental in helping us devise formulations & dosage forms for new drugs to be introduced and make variants of particular dosage forms. Most important-ly, all our manufacturing plants are headed by highly qualified experts such as Vipulam Mishra, Anil Arora and Murthy, each of whom possesses decades of extensive experience in pharma research and manufacturing", Sanjay proudly asserts.Start-Studded Business JourneyGiven the industry benchmark practices and exceptional track record that it beholds, Laborate has been conferred with many awards and recognitions ­ the prominent ones being `Udyog Rattan Award', `Emerging India Award' by ICICI & CNBC (2008) and `Excellence Award' by Institute of Economic Studies (2008). Having very recently received the EU GMP certification to operate across Europe, the company has already received two orders worth Rs.8 crore from the region. Laborate is now looking forward to acquire the Eurasia certification, which is expected to happen by the coming month and enable it to foray into Russia and surrounding countries, followed by approval from the USFDA in the days to come."With cancer cases on the rise across India lately, our nation is now being referred to as the cancer capital of the world in recent times. But despite a great demand for injectables and other lifesaving cancer medications, India is still mostly dependent on the import of such medicines from abroad due to the absence of oncology drugs manufacturing capabilities in the country. In light of this, we are now working on installing all the necessary facilities to setup a dedicate oncology unit, which will help the country ward-off reliance on foreign nations and enable us tap into the oncology market", concludes Sanjay. PO
< Page 9 | Page 11 >